Novel OPA1 mutation featuring spastic paraparesis and intestinal dysmotility

by Mohamed Kazamel, Lee-Jun Wong, Margherita Milone
Published 2014-01-01

Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis

by Thaddaeus Kwan, Mohamed Kazamel, Kristina Thoenes, Ying Si, Nan Jiang, Peter H. King
Published 2020-10-01

Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis

by Ying Si, Xianqin Cui, David K. Crossman, Jiaying Hao, Mohamed Kazamel, Yuri Kwon, Peter H. King
Published 2018-06-01

Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study...

by Ikjae Lee, Mohamed Kazamel, Tarrant McPherson, Jeremy McAdam, Marcas Bamman, Amy Amara, Daniel L Smith, Peter H King
Published 2021-01-01

FGF23, a novel muscle biomarker detected in the early stages of ALS

by Ying Si, Mohamed Kazamel, Michael Benatar, Joanne Wuu, Yuri Kwon, Thaddaeus Kwan, Nan Jiang, Dominik Kentrup, Christian Faul, Lyndsy Alesce, Peter H. King
Published 2021-06-01

Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis.

by Michael P Gustafson, Nathan P Staff, Svetlana Bornschlegl, Greg W Butler, Mary L Maas, Mohamed Kazamel, Adeel Zubair, Dennis A Gastineau, Anthony J Windebank, Allan B Dietz
Published 2017-01-01

Transforming Growth Factor Beta (TGF-β) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression.

by Ying Si, Soojin Kim, Xiangqin Cui, Lei Zheng, Shin J Oh, Tina Anderson, Mohammad AlSharabati, Mohamed Kazamel, Laura Volpicelli-Daley, Marcas M Bamman, Shaohua Yu, Peter H King
Published 2015-01-01